IDNAiShares Genomics Immunology and Healthcare ETF
Grow my money#1074 of 2944 for Grow my money
Seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from growth in genomics.
iShares · Since 2019 (6 years)
Annual Cost
0.47%
#2134 out of 5,332 ETFs
Fund Size
$150M
#2357 out of 5,332 ETFs
Dividend Yield
1.07%
Track Record
6 years
#1961 out of 5,332 ETFs
Performance
1 Year
+41.3%
3 Years
+9.2%
5 Years
-8.8%
What's inside
Asset class
Focus
Biotech & Genomics
Asset allocation
Stocks
99.6%
Cash
0.4%
Sector breakdown
Healthcare
100.0%
Top holdings
Moderna IncMRNA6.8%
Arcellx IncACLX5.4%
Ipsen SAIPN.PA4.8%
Takeda Pharmaceutical Co Ltd4502.T4.6%
Revolution Medicines Inc Ordinary SharesRVMD4.5%
Merck & Co IncMRK4.4%
Bayer AGBAYN.DE4.3%
GSK PLCGSK.L4.2%
Regeneron Pharmaceuticals IncREGN4.0%
Roche Holding AG Ordinary Shares newROP.SW3.7%
Risk profile
Volatility (1Y)
25.3%
High
Max drawdown
-68.3%
Worst peak-to-trough loss
Sharpe (3Y)
0.34
Below average
Sortino (3Y)
0.49
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05